# Gelsemium Sempervirens in Anticipatory Anxiety

> **NCT00914329** · PHASE3 · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 180 (estimated)

## Conditions studied

- Anxiety

## Interventions

- **DRUG:** Gelsemium Sempervirens
- **DRUG:** Gelsemium Sempervirens
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00914329
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2010-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914329, "Gelsemium Sempervirens in Anticipatory Anxiety". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00914329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*